Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298083) titled 'DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins' on Dec. 17, 2025.
Study Type: Observational
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Neurofibromas
MPNST
Recruitment Status: Not recruiting
Date of First Enrollment: April 1, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07298083
Published by HT Digital Content Services with permission from Health Daily Digest....